Nyxoah SA
Develops hypoglossal neurostimulation therapy for Obstructive Sleep Apnea (OSA).
NYXH | BR
Overview
Corporate Details
- ISIN(s):
- BE0974358906
- LEI:
- 5493002O1ESKZ18OXR80
- Country:
- Belgium
- Address:
- Rue Edouard Belin 12, 1435 Mont-Saint-Guibert
- Website:
- https://www.nyxoah.com/
- Sector:
- Manufacturing
Description
Nyxoah SA is a medical technology company focused on the development and commercialization of solutions for Obstructive Sleep Apnea (OSA). The company's lead product is the Genio® system, a hypoglossal neurostimulation (HNS) therapy designed for patients with moderate to severe OSA. The system features a patient-centered, leadless, and battery-free implantable stimulator. It functions by providing bilateral stimulation to the hypoglossal nerve, which controls tongue muscles, to maintain an open airway during sleep.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-07-14 22:30 |
2021 07 14 22h30 PR Transparency notification (Deerfield) (ENG).pdf
|
English | 167.3 KB | ||
| 2021-07-14 22:30 |
2021 07 14 22h30 PR Transparency notification (Deerfield) (FR).pdf
|
French | 168.9 KB | ||
| 2021-07-09 22:30 |
2021 07 09 22u30 - Press release - Number of shares (ENG) (final).pdf
|
English | 154.7 KB | ||
| 2021-07-09 22:30 |
2021 07 09 22u30 - Press release - Number of shares (FR) (final).pdf
|
French | 154.1 KB | ||
| 2021-07-08 22:30 |
Nyxoah Announces Closing of Nasdaq Initial Public Offering and Underwriters’ Fu…
|
English | 108.7 KB | ||
| 2021-07-08 22:30 |
Nyxoah Annonce la Clôture de l’Offre Publique Initiale Nasdaq et l’Exercice Int…
|
French | 139.5 KB | ||
| 2021-07-07 22:30 |
2021 07 07 22u30 - Press release - Number of shares (ENG) (final).pdf
|
English | 154.5 KB | ||
| 2021-07-07 22:30 |
2021 07 07 22u30 - Press release - Number of shares (FR) (final).pdf
|
French | 153.9 KB | ||
| 2021-07-02 14:40 |
Nyxoah Announces Pricing of Nasdaq Public Offering
|
English | 15.2 KB | ||
| 2021-07-02 14:40 |
Nyxoah Annonce la Fixation du Prix de son Offre Publique sur le Nasdaq
|
French | 17.0 KB | ||
| 2021-06-29 19:00 |
2021 06 29 - Press release - Number of shares (ENG) (final).pdf
|
English | 153.1 KB | ||
| 2021-06-29 19:00 |
2021 06 29 - Press release - Number of shares (FR) (final).pdf
|
French | 152.5 KB | ||
| 2021-06-25 12:30 |
Nyxoah Announces Launch of Proposed Public Offering in the United States
|
English | 120.0 KB | ||
| 2021-06-25 12:30 |
Nyxoah Annonce le Lancement de l'Offre Publique Proposée aux États-Unis
|
French | 147.1 KB | ||
| 2021-06-25 09:00 |
20210625 - Special auditor report - Art 7_179_7_191_7_193 - US IPO (FR) (for we…
|
French | 124.0 KB |
Automate Your Workflow. Get a real-time feed of all Nyxoah SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Nyxoah SA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Nyxoah SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-11-19 | Laurette Renard | Close relation | Sell | 5,000 | 39,000.00 EUR |
| 2024-09-05 | Hambrecht Jürgen | Board | Sell | 980,000 | 6,840,400.00 EUR |
| 2024-09-05 | JH Capital GmbH | Close relation | Buy | 980,000 | 6,840,400.00 EUR |
| 2024-01-25 | Tompkins Patrick | Executive member | Buy | 2,000 | 18,020.00 USD |
| 2023-12-28 | Onkelinx Bruno | Executive member | Buy | 470 | 2,035.10 EUR |
| 2023-08-18 | Moreau Loïc | Executive member | Buy | 6,427 | 48,416.52 EUR |
| 2023-08-14 | Moreau Loïc | Executive member | Buy | 3,800 | 28,697.60 EUR |
| 2023-08-11 | Moreau Loïc | Executive member | Buy | 3,000 | 21,957.60 EUR |
| 2023-07-04 | Wildman Ventures LLC | Board | Buy | 25,000 | N/A |
| 2023-07-02 | Gianello Pierre | Board | Buy | 25,000 | N/A |